本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ocular Therapeutix

5.57
-0.2900-4.95%
盘后:5.600.0300+0.54%19:30 EST
成交量:289.54万
成交额:1,637.75万
市值:12.26亿
市盈率:-3.82
高:5.95
开:5.76
低:5.54
收:5.86
52周最高:16.44
52周最低:5.54
股本:2.20亿
流通股本:1.83亿
量比:0.76
换手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):-1.4588
每股收益(LYR):-1.4203
净资产收益率:-93.48%
总资产收益率:-42.19%
市净率:2.78
市盈率(LYR):-3.92

数据加载中...

2026/11/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/11/09

重要事件披露

Form 8-K - Current report
2026/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/09

重要事件披露

Form 8-K - Current report
2026/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/10/16

重要事件披露

Form 8-K - Current report
2026/10/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/03

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities